Corporate
USFDA Issues 7 Observations to NATCO Pharma's Kothur Plant
NATCO Pharma has received seven observations in Form 483 from the US Food and Drug Administration after an inspection…
NATCO Pharma has received seven observations in Form 483 from the US Food and Drug Administration after an inspection…
Aurobindo Pharma said its wholly-owned subsidiary Apitoria Pharma has received a "Voluntary Action Indicated" (VAI)…
Ichnos Glenmark Innovation (IGI), the joint venture between Glenmark Pharmaceuticals and Ichnos Sciences, has submitted…
Cipla Ltd said its wholly-owned US subsidiary InvaGen Pharmaceuticals Inc has received a "No Action Indicated" (NAI)…